Over the past two decades, APL has evolved into a reliable partner for generic players and innovators worldwide. The company has expanded its capabilities through cutting-edge research and development, as well as advanced manufacturing processes.
Aarti Pharmalabs operates in several key areas:
- Generic APIs and Intermediates: Manufacturing a wide range of generic Active Pharmaceutical Ingredients and intermediates for various therapeutic categories.
- Xanthine Derivatives: Producing compounds such as caffeine and related derivatives used in pharmaceuticals and nutraceuticals.
- Contract Development and Manufacturing Organization (CDMO) Services: Offering services for drug substance development and manufacturing, focusing on clinical phases I, II, and III, as well as commercial production for innovative pharmaceutical and biotech companies.
- High-Potency APIs (HPAPIs) and Oncology Products: Operating dedicated facilities for the production of high-potency active pharmaceutical ingredients, corticosteroids, cytotoxic medicines, and oncology products.
With a commitment to integrating process chemistry proficiency with scale-up engineering expertise, Aarti Pharmalabs aims to build a sustainable future in the pharmaceutical industry.